Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
DiaMedica Therapeutics Inc
NASDAQ:DMAC
Price:
8.42
USD
2.31%
Market Closed
Market Cap:
$453.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
US |
|
S
|
Siemens Healthineers AG
XMUN:SHL
|
DE |
|
M
|
Mildef Crete Inc
TPEX:3213
|
TW |
|
H
|
Hub Power Company Ltd
KAR:HUBC
|
PK |
|
European Resources Ltd
ASX:ERE
|
AU |
|
Decisive Dividend Corp
F:PC9
|
CA |
|
Next Biometrics Group ASA
OSE:NEXT
|
NO |
|
F
|
Fusemachines Inc
NASDAQ:FUSE
|
US |
Wall St Price Targets
DMAC Price Forecast
Based on 5 analysts
Based on 5 analysts
+70% Upside
from
$8.42
today
DiaMedica Therapeutics Inc (DMAC)’s 12-month stock price forecast through October 2027 has a consensus target of $14.28, implying 70% upside. The forecast is based on price targets from 5 Wall Street analysts.
DMAC Analyst Rating
Based on 5 analysts
Based on 5 analysts
Analysts rate DMAC Strong buy, with 5 of 5 recommending Buy or Strong buy.
DiaMedica Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMAC's stock price target?
Price Target
14.28
USD
14.28
USD
According to Wall Street analysts, the average 1-year price target for DMAC is 14.28 USD with a low forecast of 12.12 USD and a high forecast of 26.25 USD.